Coming Soon from Emmaus Medical, Inc.



Emmaus Medical, Inc. takes all reasonable steps to protect the privacy of visitors to our Web Site. Emmaus only collect personally identifiable data, such as name, address, telephone number or e-mail addresses, when voluntarily submitted to us at this Web site (“Site”). Emmaus and/or the companies we hire will use this information to comply with your request or inquiry, or as otherwise disclosed to you at the Site location where you submit your information. When necessary, we may refer to that information to better understand your needs and how we can improve our products and services. We may use that information to contact you. However, we will not sell or otherwise transfer the personally identifiable information provided at this Site to any third party unless otherwise disclosed to you when you submit your information.

Emmaus Medical, Inc. also uses information in aggregate form to track the number of visitors to our site, the number of visitors to each page, and the domain names of our visitors' Internet service providers. No personally identifiable information is available in this process. Some sections in the Emmaus Site may use a technology called "cookies". A cookie is a token that a server gives to your browser when you access a Web site. Cookies are capable of storing many types of data. They also help provide additional functionality to the site or help us analyze site usage more accurately. For instance, our server may set a cookie that keeps you from having to enter a password more than once during a visit to one of our sites. In all cases in which cookies are used, the cookie will not collect personally identifiable information except with explicit permission.

Emmaus Medical, Inc.'s Web site is not intended or designed to attract children under the age of 13. We do not collect personally identifiable data from any person we know to be under the age of 13.

As a convenience to readers, Emmaus Medical's Web site might contain links to other sites. The privacy policies and procedures described here do not apply to those sites. We suggest contacting those sites directly for information on data collection and distribution policies.

Any changes to this Emmaus Medical Internet Privacy Statement will be promptly posted on this page.

If you have concerns about this Privacy Policy or our privacy practices in general, contact us at:

Emmaus Medical, Inc.
21250 Hawthorne Blvd., Suite 800
Torrance, CA 90503
Fax: 310-214-0075


Endari™ [L-glutamine oral powder] is an FDA-approved prescription drug indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.


Endari’s safety profile was similar to placebo and well-tolerated in pediatric and adult patients. The most common adverse reactions occurring in greater than 10 percent of patients treated with Endari were constipation, nausea, headache, abdominal pain, cough, pain in extremity, back pain, and chest pain (non-cardiac).

Endari should only be taken under the direction of a physician. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

The information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries. Use and access of this site is subject to the terms and conditions as set out in our Terms of Use and Internet Privacy Policy.

For additional information about Endari, please read the Endari Full Prescribing Information and talk to your doctor. You can also call 1-877-420-6493. Endari is available by prescription only.

You may report side effects to FDA at 1-800-FDA-1088.